U.S. Markets closed

(LPTN)


NasdaqCM . Currency in USD
Add to watchlist
People also watch
MCURTLOGEBIOSPHSBSPM
Full screen
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com7 months ago

    Apollo Endosurgery Shares Up 20% After Going Public With Reverse Merger

    The deal, first announced in September, resulted from a strategic review initiated last year by Lpath.

  • Lpath, Inc. :LPTN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016
    Capital Cube8 months ago

    Lpath, Inc. :LPTN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016

    Categories: Yahoo Finance Get free summary analysis Lpath, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Lpath, Inc. – PDL BioPharma, Inc., Pfizer Inc., Gilead Sciences, Inc., Acorda Therapeutics, Inc. and Merck & Co., Inc. (PDLI-US, PFE-US, GILD-US, ACOR-US and MRK-US) that have also reported ... Read more (Read more...)

  • Capital Cube11 months ago

    Lpath, Inc. :LPTN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis Lpath, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Lpath, Inc. – PDL BioPharma, Inc., Ohr Pharmaceutical, Inc., Gilead Sciences, Inc., Pfizer Inc., Acorda Therapeutics, Inc. and Merck & Co., Inc. (PDLI-US, OHRP-US, GILD-US, PFE-US, ACOR-US ... Read more (Read more...)